HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

1- phenyl- 3- methyl- 6- trifluoromethyl- pyrazolo(3,4- d)pyrimidine- 4(5H)thione

structure given in first source

Also Known As:

F-PPT

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrimidines: 510
    - 1-phenyl-3-methyl-6-trifluoromethyl-pyrazolo(3,4-d)pyrimidine-4(5H)thione: 1

Experts

1.	Berhe, Nega: 1 article (02/2008)
2.	Gundersen, Svein G: 1 article (02/2008)
3.	Myrvang, Bjørn: 1 article (02/2008)

Related Diseases

1.

Fibrosis (Cirrhosis)

02/01/2008 - "To study outcome determinants of schistosomal periportal thickening/fibrosis (PPT/F), 199 subjects (mean age = 24.0 years, range = 7-68 years), 109 with mild (image pattern C) PPT/F, 69 with moderate (image pattern D) PPT/F, and 21 with severe (image patterns E and F) PPT/F were treated with praziquantel and evaluated every six months for a mean duration of 26 months. "

Related Drugs and Biologics

1.	Praziquantel (Biltricide)